Bays HE, Kulkarni A, German C, Satish P, Iluyomade A, Dudum R, et al. Ten things to know about ten cardiovascular disease risk factors – 2022. Am J Prev Cardiol. 2022;10:100342.
Article
Google Scholar
Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;328:313–8.
Article
CAS
Google Scholar
Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987;257:2176–80.
Article
CAS
Google Scholar
Carbayo Herencia JA, Simarro Rueda M, Palazon Bru A, Molina Escribano F, Ponce Garcia I, Artigao Rodenas LM, et al. Todos en nombre del Grupo de Enfermedades Vasculares de Albacete (GEVA). Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort. Clin Investig Arterioscler. 2018;30:64–71.
Google Scholar
Nishizawa Y, Shoji T, Kakiya R, Tsujimoto Y, Tabata T, Ishimura E, et al. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl. 2003;84:S117–20.
Article
CAS
Google Scholar
Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WR, et al. Haemostatic function and ischemic heart disease: principal results oft he Northwick Park heart study. Lancet. 1986;2:533–7.
Article
CAS
Google Scholar
Baker IA, Eastham R, Elwood PC, Etherington M, O’Brien JR, Sweetnam PM. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell. Study Br Heart J. 1982;47:490–4.
Article
CAS
Google Scholar
Folsom AR, Conlan MG, Davis CED, Wu KK. For the atherosclerosis in communities (ARIC) study investigators. Relations between hemostasis variables and cardiovascular risk factors in middle-aged adults. Ann Epidemiol. 1992;2:481–94.
Article
CAS
Google Scholar
Maseri A, Fuster V. Is there a vulnerable plaque? Circulation. 2003;107:2068–71.
Article
Google Scholar
Song B, Shu Y, Xu YN, Fu P. Plasma fibrinogen level and risk of coronary heart disease among Chinese population: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8:13195–202.
CAS
Google Scholar
Lowe G, Rumley A. The relevance of coagulation in cardiovascular disease: what do the biomarkers tell us? Thromb Haemost. 2014;112:860–7.
Article
Google Scholar
El-Hazmi MA. Hematological risk factors for coronary heart disease. Med Princ Pract. 2002;11(Suppl 2):56–62.
Article
Google Scholar
Georgieva AM, Cate HAT, Keulen ETP, van Oerle R, Govers-Riemslag JWP, Hamulyak K, et al. Prothrombotic markers in familial combined hyperlipidemia: evidence of endothelial cell activation and relation to metabolic syndrome. Atherosclerosis. 2004;175:345–51.
Article
CAS
Google Scholar
Woodward M, Lowe GDO, Rumley A, Tunstall-Pedoe H, Philippou H, Lane DA, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the third Glasgow MONICA survey II. Relationships to cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol. 1997;97:785–97.
Article
CAS
Google Scholar
Wada H, Mori Y, Kaneko T, Wakita Y, Minamikawa K, Ohiwa M, et al. Hypercoagulable state in patients with hypercholesteriolemia: effects of pravastin. Clin Ther. 1992;14:829–34.
CAS
Google Scholar
Poredos P, Jezovnik MK. Dyslipidemia, statins, and venous thromboembolism. Semin Thromb Hemost. 2011;37:897–902 Review.
Article
CAS
Google Scholar
Löwel H, Döring A, Schneider A, Heier M, Thorand B, Meisinger C, et al. The MONICA Augsburg surveys – basis for prospective cohort studies. Gesundheitswesen. 2005;67(Suppl 1):S13–8.
Article
Google Scholar
Meisinger C, Thorand B, Schneider A, Stieber J, Döring A, Löwel H. Sex differences in risk factors for incident type 2 diabetes mellitus: the MONICA Augsburg cohort study. Arch Intern Med. 2002;162:82–9.
Article
Google Scholar
Meisinger C, Löwel H, Thorand B, Döring A. Leisure time physical activity and the risk of type 2 diabetes in men and women from the general population. The MONICA/KORA Augsburg Cohort Study. Diabetologia. 2005;48:27–34.
Article
CAS
Google Scholar
Meisinger C, Döring A, Thorand B, Löwel H. Association of cigarette smoking and tar and nicotine intake with the development of type 2 diabetes mellitus in men and women from the general population: the MONICA/KORA Augsburg cohort study. Diabetologia. 2006;49:1770–6.
Article
CAS
Google Scholar
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use oft he preparative ultracentrifuge. Clin Chem. 1972;18:499–502.
Article
CAS
Google Scholar
Hansen JB, Grimsgaard S, Huseby N, Sandset PM, Bonaa KH. Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men. Thromb Res. 2001;102:3–13.
Article
CAS
Google Scholar
Conlan MG, Folsom AR, Finch A, Davis CE, Sorlie P, Wu KK. Correlation of plasma protein C levels with cardiovascular risk factors in middle-aged adults: the atherosclerosis risk in communities (ARIC) study. Thromb Haemost. 1993;70:762–7.
Article
CAS
Google Scholar
Koscielniak B, Wypasek E, Undas A. Determinants of elevated levels of natural anticoagulants in healthy subjects. Adv Clin Exp Med. 2015;24:791–800.
Article
Google Scholar
Trigg DE, Wood MG, Kouides PA, Kadir RA. Hormonal influences on hemostasis in women. Semin Thromb Hemost. 2011;37:077–86.
Article
CAS
Google Scholar
High KA. Antithrombin III, protein C, and protein S. Naturally occurring anticoagulant proteins. Arch Pathol Lab Med. 1988;112:28–36.
CAS
Google Scholar
Folsom AR, Wu KK, Davis CE, Conlan MG, Sorlie PD, Szklo M. Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors. Atherosclerosis. 1991;91:191–205.
Article
CAS
Google Scholar
Kario K, Matsuo T. Lipid-related hemostatic abnormalities in the elderly: imbalance between coagulation and fibrinolysis. Atherosclerosis. 1993;103:131–8.
Article
CAS
Google Scholar
Kostka B, Para J, Drygas W, Kostka T. Antithrombin III activity in the elderly – association with cardiovascular disease risk factors. Przegl Lek. 2005;62(Suppl 3):35–8.
Google Scholar
Lee AJ, Smith WCS, Lowe GDO, Tunstall-Pedoe H. Plasma fibrinogen and coronary risk factors. The Scottish heart health study. J Clin Epidemiol. 1990;43:913–9.
Article
CAS
Google Scholar
Balleisen L, Assmann G, Bailey J, Epping PH, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population: II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions. Thromb Haemost. 1985;54:721.
Article
CAS
Google Scholar
Moller L, Kristensen TS. Plasma fibrinogen and ischemic heart disease risk factors. Arterioscler Thromb. 1991;11:344.
Article
CAS
Google Scholar
Korsan-Bengtsen K, Wilhelmsen L, Tibblin G. Blood coagulation and fibrinolysis in a random sample of 788 men 54 years old. II. Relations of the variables to “risk factors” for myocardial infarction. Thromb Diathes Haemorrh. 1972;28:99.
CAS
Google Scholar
Kannel WB, Wolf PA, Castelli WP, D’Agostino RB. Fibrinogen and risk of cardiovascular disease. Thr Framingham Study. JAMA. 1987;258:1183.
Article
CAS
Google Scholar
Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br Med J. 1979;1:153.
Article
CAS
Google Scholar
Bonithon-Kopp C, Scarabin PY, Bara L, Castanier N, Jacqueson A, Roger M. Relationship between sex hormones and haemostatic factors in healthy middle-aged men. Atherosclerosis. 1988;71:71.
Article
CAS
Google Scholar
Lew J, Sanghavi M, Ayers CR, McGuire DK, Omland T, Atzler D, et al. Sex-based differences in cardiometabolic biomarkers. Circulation. 2017;135:544–55.
Article
CAS
Google Scholar
Chan P, Tomlinsoin B, Tsai CW, Pan WH, Lee YS. Thrombophilia in patients with hypercholesterolemia. Metabolism. 1996;45:966–99.
Article
CAS
Google Scholar
Kim JA, Kim JE, Song SH, Kim HK. Influence of blood lipids on global coagulation test results. Ann Lab Med. 2015;35:15–21.
Article
CAS
Google Scholar
Chan P, Huang TY, Shieh SM, Lin TS, Tsai CW. Thrombophilia in patients with hypertriglyceridemia. J Thromb Thrombolysis. 1997;4:425–9.
Article
CAS
Google Scholar
Kowaka T, Abumiya T, Kimura T, Harada-Shiba M, Koh H, Tsushima M, et al. Tissue factor pathway inhibitor activity in human plasma. Arterioscler Thromb Vasc Biol. 1995;15:504–10.
Article
Google Scholar
Wun TC, Kretzmer KK, Girard TJ, Miletich JP, Broze GJ. Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitorydomains. J Biol Chem. 1988;263:6001–4.
Article
CAS
Google Scholar
Rao LVM, Rapaport SI. Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. Blood. 1987;69:645–51.
Article
CAS
Google Scholar
Hansen JB, Huseby NE, Sandset PM, Svensson B, Lyngmo V, Nordoy A. Tissue factor pathway inhibitor and lipoproteins: evidence for association with and regulation by LDL in human plasma. Arterioscler Thromb. 1994;14:223–9.
Article
CAS
Google Scholar
Sandset PM, Larsen ML, Abildgaard U, Lindahl AK, Odegaard OR. Chromogenic substrate assay of extrinsic pathway inhibitor (EPI): levels in the normal population and relation to cholesterol. Blood Coagul Fibrinolysis. 1991;2:425–33.
Article
CAS
Google Scholar